Massachusetts Financial Services’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-304,027
Closed -$7.56M 885
2018
Q1
$7.56M Sell
304,027
-123,881
-29% -$3.01M ﹤0.01% 644
2017
Q4
$10.4M Sell
427,908
-69,802
-14% -$1.84M ﹤0.01% 612
2017
Q3
$13.7M Sell
497,710
-423,288
-46% -$11.3M 0.01% 552
2017
Q2
$23.1M Buy
920,998
+330,723
+56% +$8.19M 0.01% 496
2017
Q1
$15.8M Sell
590,275
-252,277
-30% -$6.97M 0.01% 527
2016
Q4
$22.1M Sell
842,552
-131,865
-14% -$3.26M 0.01% 487
2016
Q3
$24.4M Sell
974,417
-43,188
-4% -$1.01M 0.01% 474
2016
Q2
$22.1M Buy
1,017,605
+99,209
+11% +$1.77M 0.01% 482
2016
Q1
$13.8M Sell
918,396
-441,502
-32% -$7.4M 0.01% 535
2015
Q4
$29.8M Sell
1,359,898
-9,686
-0.7% -$181K 0.02% 427
2015
Q3
$21.6M Buy
1,369,584
+119,875
+10% +$1.92M 0.01% 473
2015
Q2
$17.9M Buy
1,249,709
+439,851
+54% +$7.45M 0.01% 549
2015
Q1
$14M Buy
809,858
+16,449
+2% +$291K 0.01% 592
2014
Q4
$14.2M Buy
793,409
+701,568
+764% +$11.3M 0.01% 585
2014
Q3
$1.21M Sell
91,841
-2,530
-3% -$34.1K ﹤0.01% 770
2014
Q2
$1.36M Sell
94,371
-1,505,855
-94% -$19.7M ﹤0.01% 762
2014
Q1
$20.4M Sell
1,600,226
-262,860
-14% -$3.43M 0.01% 495
2013
Q4
$18.6M Sell
1,863,086
-18,330
-1% -$208K 0.01% 484
2013
Q3
$24.8M Sell
1,881,416
-187,450
-9% -$2.46M 0.02% 436
2013
Q2
$29.5M Buy
+2,068,866
New +$26M 0.02% 394

Other funds holding NXTM

Massachusetts Financial Services's NXTM Position: Q2 2018 in Review

Massachusetts Financial Services sold out of NxStage Medical Inc. (NXTM) in Q2 2018, closing a stake of 304,027 shares — an estimated $7.56M sold.

Massachusetts Financial Services first reported a position in NXTM in Q2 2013 and held it in 20 quarters. The position peaked at $29.8M in Q4 2015. 171 funds tracked by Wall St. Rank hold NXTM as of Q2 2018.

  • Massachusetts Financial Services reported no remaining NxStage Medical Inc. position as of Q2 2018 after selling out during the quarter.
  • Massachusetts Financial Services sold 304,027 NxStage Medical Inc. shares in Q2 2018, an estimated $7.56M.
  • Massachusetts Financial Services first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 20 quarters.
  • Massachusetts Financial Services's NxStage Medical Inc. position peaked at $29.8M in Q4 2015.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2018.

Based on Massachusetts Financial Services's 13F filing for Q2 2018, filed 30 Jul 2018.